Dosage of heparin for patency of the totally implanted central venous catheter in cancer patients

Authors

DOI:

https://doi.org/10.1590/1518-8345.3326.3304

Keywords:

Vascular Access Devices, Central Venous Catheters, Indwelling Catheters, Heparin, Heparin Lock, Catheter Obstruction

Abstract

Objective: to analyze the evidence available in the literature about the lowest necessary dose of heparin to maintain the patency of the totally implanted central venous catheter in adult cancer patients. Method: an integrative literature review, carried out in the following databases: Literatura Latino-Americana e do Caribe em Ciências de Saúde, Sciverse Scopus, Web of Science, Cumulative Index to Nursing and Allied Health Literature, Cochrane Central Register of Controlled Trials, including thirteen studies. Results: the evidence showed that the dose of heparin (300 IU/ml) is the most used in maintaining the patency of the totally implanted central venous catheter. Conclusion: according to the selected studies, the lowest dose of heparin found in maintaining the patency of the totally implanted central venous catheter in cancer patients was 10 UN/ml with a volume of 5 ml of the heparin solution.

Downloads

Download data is not yet available.

Published

2020-06-19

Issue

Section

Review Article

How to Cite

Dosage of heparin for patency of the totally implanted central venous catheter in cancer patients. (2020). Revista Latino-Americana De Enfermagem, 28, e3304. https://doi.org/10.1590/1518-8345.3326.3304